focus -WSS

focus

author：fashion 2025-10-02 16:18:48 - browse：4

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： House panel takes first step toward fixing drug shortages

WSS

Antivenom research: Lessons from HIV applied in search for universal antidote

Information blocking fines are now fair game in health care

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Information blocking fines are now fair game in health care

Alabama frozen embryo ruling has major implications for IVF clinics

Medicare inequities exacerbate Puerto Rico’s health disparities

knowledge

focus

focus

Trump demands the U.S. pay no more for drugs than other countries … again

NIH study of ME/CFS points to clear biological hallmarks

As demand for Covid shots wanes, Moderna seeks its next success

Why palliative psychiatry is worth discussing

After affirmative action ruling, medical educators look to 'holistic review'

Medicare inequities exacerbate Puerto Rico’s health disparities

Malaria cases in Florida and Texas: Here’s what you need to know

6 phony surgeries that take placebo to the extreme

Apple is now the first public company to be valued at $3 trillion

R1 RCM gets $5.8 billion buyout offer from private equity firm

Wikipedia

Medicare inequities exacerbate Puerto Rico’s health disparities

Akili changes sales model for its ADHD video game treatment

Community Health Systems hospitals under DOJ investigation

A solution to the after

With competition flaring, obesity drug hits goal in liver disease study

FDA panel to weigh safety of artificial wombs for preterm births

focus

entertainment

focus

hotspot